Collegium Pharmaceutical, Inc. (COLL)

Collegium Pharmaceutical Revenue

Collegium Pharmaceutical had revenue of $193.52M in the quarter ending March 31, 2026, with 8.87% growth. This brings the company's revenue in the last twelve months to $796.33M, up 19.88% year-over-year. In the year 2025, Collegium Pharmaceutical had annual revenue of $780.57M with 23.62% growth.

• Revenue (ttm): $796.33M
• Revenue Growth: +19.88%
• P/S Ratio: 1.45
• Revenue / Employee: $1,882,577
• Employees: 423
• Market Cap: 1.16B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	780.57M	149.12M	23.62%
Dec 31, 2024	631.45M	64.68M	11.41%
Dec 31, 2023	566.77M	102.83M	22.17%
Dec 31, 2022	463.93M	187.07M	67.56%
Dec 31, 2021	276.87M	-33.15M	-10.69%
Dec 31, 2020	310.02M	13.32M	4.49%
Dec 31, 2019	296.70M	16.29M	5.81%
Dec 31, 2018	280.41M	251.94M	884.73%
Dec 31, 2017	28.48M	26.77M	1,564.29%
Dec 31, 2016	1.71M	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-

Data Source: Fiscal.ai Last updated: May 7, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 28, 2026

Data Sources Report a data error